share_log

Cantor Fitzgerald Reiterates Neutral on PAVmed, Maintains $1.4 Price Target

Benzinga ·  Aug 18, 2023 10:46

Cantor Fitzgerald analyst Ross Osborn reiterates PAVmed (NASDAQ:PAVM) with a Neutral and maintains $1.4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment